Retrospective cohort study evaluates treatment approaches in primary open-angle glaucoma, highlighting surgical benefits.
Purpose To characterize short-term structural and functional progression trajectories in medically uncontrolled primary open-angle glaucoma (POAG) managed with adjunctive netarsudil intensification or immediate surgical escalation.Methods This retrospective cohort study included 110 eyes with POAG receiving maximally tolerated medical therapy. Thirty-seven eyes underwent netarsudil intensification and 73 eyes underwent trabeculectomy or tube shunt surgery. Stabilized inverse probability weighting was applied to balance baseline covariates. The primary outcome was the 12-month slope of visual field mean deviation (MD). Secondary outcomes included retinal nerve fiber layer (RNFL) thinning rate and intraocular pressure (IOP) reduction.Results The estimated MD progression rate was −0.61 ± 0.58 dB/year in the netarsudil group and −0.42 ± 0.55 dB/year in the surgical group (between-group difference −0.17 dB/year; 95% CI, −0.38 to 0.04; p = .112). RNFL thinning rates were −1.8 ± 2.1 µm/year and −1.1 ± 1.9 µm/year, respectively (between-group difference −0.7 µm/year; 95% CI, −1.6 to 0.2; p = .138). Surgical management achieved greater IOP reduction (−12.3 ± 3.8 mmHg vs − 5.4 ± 2.3 mmHg; p < .001). During follow-up, 27% of eyes in the netarsudil group required subsequent surgical escalation.Conclusions Although surgery achieved greater IOP reduction, short-term structural and functional trajectories remained similar after treatment escalation over 12 months.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: